December 01, 2003 article Thirty‐five years of Rh prophylaxis Transfusion DOI: 10.1111/j.0041-1132.2003.00632.x OpenAlex Authors 0 Author list not loaded yet. Cited by 4 stored of 138 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Achieving sustainable anti‐ D immunoprophylaxis in Europe 2026 Vox Sanguinis article Medicine Blood groups and transfusion 0 citations Design of a Phase 3, Global, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn 2024 American Journal of Perinatology article Medicine Blood groups and transfusion Open access 29 citations Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn 2024 New England Journal of Medicine article Medicine Blood groups and transfusion cited by 1 patent 112 citations Identification and management of fetal anemia due to hemolytic disease 2022 Expert Review of Hematology article Medicine Blood groups and transfusion Open access 38 citations 4 results References 0